These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4557738)

  • 1. Effect of concomitant drug treatment on toxic and therapeutic activity of 5-fluorouracil (5-FU; NSC-19893).
    Moertel CG; Reitemeier RJ; Hahn RG
    Cancer Chemother Rep; 1972 Apr; 56(2):245-7. PubMed ID: 4557738
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-day iv infusion with 5-fluorouracil (5-FU; NSC-19893) for gastroenteric carcinoma after failure on weekly 5-FU therapy.
    Hum GJ; Bateman JR
    Cancer Chemother Rep; 1975; 59(6):1171-9. PubMed ID: 769960
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside.
    Gailani S; Holland JF; Falkson G; Leone L; Burningham R; Larsen V
    Cancer; 1972 May; 29(5):1308-13. PubMed ID: 4623252
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlled clinical studies of orally administered antiemetic drugs.
    Moertel CG; Reitemeier RJ
    Gastroenterology; 1969 Sep; 57(3):262-8. PubMed ID: 4186220
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Baker LH; Vaitkevicius VK; Gehan E
    Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma.
    Abdallah AM; Soukop M; Bell G; Calman KC
    Clin Oncol; 1977 Sep; 3(3):247-57. PubMed ID: 334430
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination therapy with 5-fluorouracil (5-FU; NSC-19893) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for disseminated gastrointestinal carcinoma.
    Lokich JJ; Skarin AT
    Cancer Chemother Rep; 1972 Oct; 56(5):653-7. PubMed ID: 4569058
    [No Abstract]   [Full Text] [Related]  

  • 8. [5-Fluorouracil(5-FU) in the treatment of adenocarcinomas of the digestive tract (apropos of 13 cases)].
    Vinhafs JC; Ferreira AJ
    Hospital (Rio J); 1967 Feb; 71(2):453-74. PubMed ID: 5302398
    [No Abstract]   [Full Text] [Related]  

  • 9. Adriamycin (NSC-123127) therapy for advanced gastrointestinal cancer.
    Frytak S; Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    Cancer Chemother Rep; 1975; 59(2 Pt 1):405-9. PubMed ID: 1097099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of adenocarcinoma with combinations of cyclopjosphamide (NSC-26271), vincristine (NSC-67574), and 5-fluorouracil (NSC-19893).
    Tucker WG; Talley RW; Lane M; Bonnet JD
    Cancer Chemother Rep; 1975; 59(2 Pt 1):425-7. PubMed ID: 1097101
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of 5-fluorouracil (NSC-19893) in 389 patients with cancer. Eastern Clinical Drug Evaluation Program.
    Moore GE; Bross ID; Ausmans R; Nadler S; Jones R; Slack N; Rimm AA
    Cancer Chemother Rep; 1968 Oct; 52(6):641-53. PubMed ID: 4895427
    [No Abstract]   [Full Text] [Related]  

  • 12. [5-Fluorouracil in the treatment of gastrointestinal tumors].
    Aran M; Bilge N; Ozman M
    Turk Tip Dernegi Derg; 1973; 39(12):459-65. PubMed ID: 4377630
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot study.
    Machover D; Schwarzenberg L; Goldschmidt E; Tourani JM; Michalski B; Hayat M; Dorval T; Misset JL; Jasmin C; Maral R; Mathé G
    Cancer Treat Rep; 1982 Oct; 66(10):1803-7. PubMed ID: 6982099
    [No Abstract]   [Full Text] [Related]  

  • 15. [Action of metopimazine on gastric motility. Double-blind study using external digestive electromyography].
    Bertrand J; Thillier JL
    Nouv Presse Med; 1975 Oct; 4(32):2319-20. PubMed ID: 1101213
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic arterial infusion for liver metastases from colon cancer: comparison of mitomycin C(NSC-26980) and 5-fluorouracil (NSC-19893).
    Fortuny IE; Theologides A; Kennedy BJ
    Cancer Chemother Rep; 1975; 59(2 Pt 1):401-4. PubMed ID: 1097098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
    Cedermark BJ; Didolkar MS; Elias EG
    Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of adriamycin (NSC-123127) and 5-fluorouracil (NSC-19893) in advanced prostatic cancer.
    DeWys WD
    Cancer Chemother Rep; 1975; 59(1):215-7. PubMed ID: 1093668
    [No Abstract]   [Full Text] [Related]  

  • 19. Prediction of 5-fluorouracil and cisplatin synergism for advanced gastrointestinal cancers using a collagen gel droplet embedded culture.
    Mori S; Kunieda K; Sugiyama Y; Saji S
    Surg Today; 2003; 33(8):577-83. PubMed ID: 12884094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oxytetracycline, vehicle for therapeutic drugs, fluorouracil and nitrogen mustard, in the treatment of gastrointestinal tumors].
    Gordon B
    Hospital (Rio J); 1970 Apr; 77(4):1243-68. PubMed ID: 4939509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.